Label-Free Multiplex SERS Microfluidic Immunoassay of Breast Cancer Biomarkers in Serum Using Directionally Conjugated mAb-Gold Nanourchins on a PCB-Thin Gold Film Platform
Plasmonics · 23.12.2025 · 21 (2) · 1755-1776
DOI: 10.1007/s11468-025-03332-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plasmonics, online erschienen am 23.12.2025. Verfasst von Mohammad E. Khosroshahi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Khosroshahi, M. E., Senthilchelvan, G., Pezeshki, A., & Oyebolu, V. (2025). Label-Free Multiplex SERS Microfluidic Immunoassay of Breast Cancer Biomarkers in Serum Using Directionally Conjugated mAb-Gold Nanourchins on a PCB-Thin Gold Film Platform. Plasmonics, 21(2), 1755-1776. https://doi.org/10.1007/s11468-025-03332-6
Vancouver
Khosroshahi ME, Senthilchelvan G, Pezeshki A, Oyebolu V. Label-Free Multiplex SERS Microfluidic Immunoassay of Breast Cancer Biomarkers in Serum Using Directionally Conjugated mAb-Gold Nanourchins on a PCB-Thin Gold Film Platform. Plasmonics. 2025;21(2):1755-1776. doi:10.1007/s11468-025-03332-6
BibTeX
@article{Khosroshahi2025,
author = {Khosroshahi, Mohammad E. and Senthilchelvan, Gayathri and Pezeshki, Adam and Oyebolu, Victor},
title = {Label-Free Multiplex SERS Microfluidic Immunoassay of Breast Cancer Biomarkers in Serum Using Directionally Conjugated mAb-Gold Nanourchins on a PCB-Thin Gold Film Platform},
journal = {Plasmonics},
year = {2025},
volume = {21},
number = {2},
pages = {1755--1776},
doi = {10.1007/s11468-025-03332-6}
}
EUVIMED